Recruiting NA INTERVENTIONAL 2-arm
NCT07097415
The Application of Continuous Blood Glucose Monitoring in Optimizing the Management of Type 2 Diabetes
The Application of Continuous Blood Glucose Monitoring in Optimizing the Management of Early Onset and Late Onset Type 2 Diabetes: an Effectiveness - Implementation Type Ⅱ Hybrid Design Quasi-experimental Pragmatic Trial
Sponsor: Peking University
Updated 1 time since 2025 Last updated: Jul 30, 2025 Started: Nov 15, 2024 Primary completion: Sep 30, 2025 Completion: Nov 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Continuous Glucose Monitoring and Type 2 Diabetes (T2DM) and is currently actively recruiting participants. Peking University leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Peking University
Data source: Peking University
For direct contact, visit the study record on ClinicalTrials.gov .